Image

Asia-Pacific Sleep Disorder Treatment Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Feb 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 226
  • No of Figures: 49
  • Healthcare
  • Published Report
  • Feb 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 226
  • No of Figures: 49

Asia-Pacific Sleep Disorder Treatment Market, By Type (Insomnia, Sleep Apnea, Restless Legs Syndrome (RLS), Narcolepsy and Others), Treatment (Pharmacological Therapy, Mechanical Therapy, Mandibular Advancement Devices, Hypoglossal Nerve Stimulator, Surgery and Others), Route of Administration (Oral, Parenteral and Others), Drugs Type (Generics and Branded), Population Type (Adults and Children), End User (Hospitals, Specialty Clinics, Home Healthcare, Ambulatory Surgical Center and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others), Country (Japan, China, India, South Korea, Australia, Singapore, Thailand, Vietnam, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific) Industry Trends and Forecast to 2028

Asia-Pacific Sleep Disorder Treatment Market Market Analysis and Insights : Asia-Pacific Sleep Disorder Treatment Market

Asia-Pacific sleep disorder treatment market is expected to reach USD 435.01 million by 2028, from USD 251.28 million in 2020, growing at the CAGR of 7.3% in the forecast period of 2021 to 2028. Asia-Pacific sleep disorder treatment market is expected to grow due the increased prevalence of sleep disorders like sleep apnea, insomnia and narcolepsy across globe.

Sleep disorders are also known as somnipathy. It comprises of various medical conditions which deviates the sleeping pattern of a person negatively. Sleep disorders can also be defined as a group of disorders impacting sleep pattern of an individual on a regular basis. Various factors are responsible for the presence of sleep disorders which includes lifestyle changes and high stress among other. The sleep disorders impacts the overall health of a person along with affecting their level of concentration leading to tiredness throughout the day.

Sleep apnea, insomnia, sleep walking, narcolepsy and restless leg syndrome (RLS) are some of the common sleep disorders observed across globe. The increased lifestyle changes, growing adoption of gadgets and increased use of social media are surging the prevalence of sleeping disorders across various regions in the world.

The sleep disorder treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Sleep Disorder Treatment Market Asia-Pacific Sleep Disorder Treatment Market Scope and Market Size

The sleep disorder treatment market is categorized into seven notable segments which are based on the type, treatment, route of administration, drugs type, population type, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the sleep disorder treatment market is segmented into insomnia, sleep apnea, restless legs syndrome (RLS), narcolepsy and others. In 2021, insomnia segment is expected to dominate the Asia-Pacific sleep disorder treatment market because of the technological advancement in order to develop innovative treatment options for the particular disorder.
  • On the basis of treatment, the sleep disorder treatment market is segmented into pharmacological therapy, mechanical therapy, mandibular advancement devices, hypoglossal nerve stimulator, surgery and others. In 2021, pharmacological therapy segment is expected to dominate the Asia-Pacific sleep disorder treatment market because numerous classes of medications are available for the treatment of sleep disorder as per the symptoms of patients.
  • On the basis of route of administration, the sleep disorder treatment market is segmented into oral, parenteral and others. In 2021, oral segment is expected to dominate the Asia-Pacific sleep disorder treatment market because of the increased availability of oral drugs for the treatment of sleep disorders like narcolepsy, restless legs syndrome (RLS) and insomnia among others.
  • On the basis of drugs type, the sleep disorder treatment market is segmented into branded and generics. In 2021, generics segment is expected to dominate the Asia-Pacific sleep disorder treatment market because of the increased availability of generic drugs for the treatment of sleep disorders like Gabapentin, Zolpidem ER Tablets and Eszopiclone Tablets, CIV among others.
  • On the basis of population type, the sleep disorder treatment market is segmented into children and adults. In 2021, adults segment is expected to dominate the Asia-Pacific sleep disorder treatment market due to the surging geriatric population across globe requiring more advanced treatment options.
  • On the basis of end user, the sleep disorder treatment market is segmented into hospitals, specialty clinics, home healthcare, ambulatory surgical center and others. In 2021, hospitals segment is expected to dominate the Asia-Pacific sleep disorder treatment market due to the financial capabilities of hospitals to purchase expensive equipment used in surgery along with the presence of trained professionals to operate the mechanical devices and prescribed medications.
  • On the basis of distribution channel, the sleep disorder treatment market is segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others. In 2021, direct tender segment is expected to dominate the Asia-Pacific sleep disorder treatment market as most of the drugs are procured through direct tender services.

Sleep Disorder Treatment Market Country Level Analysis

The sleep disorder treatment market is categorized into segments which are based on the country, type, treatment, route of administration, drugs type, population type, end user and distribution channel.

The Asia-Pacific sleep disorder treatment market on the basis of country is segmented into Japan, China, India, South Korea, Australia, Singapore, Thailand, Vietnam, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific.

In Asia-Pacific, Japan is expected to dominate because of the technological advancements in order to develop innovative treatment options for the particular disorder.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

New Product Launches by Manufactures is Creating New Opportunities for Players in the Sleep Disorder Treatment Market

Sleep disorder treatment market also provides you with detailed market analysis for every country growth in aesthetic industry with sleep disorder treatment market sales, impact of advancement in the sleep disorder treatment market and changes in regulatory scenarios with their support for the sleep disorder treatment market. The data is available for historic period 2011 to 2019.

Competitive Landscape and Sleep Disorder Treatment Market Share Analysis

Sleep disorder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to sleep disorder treatment market.

The major players covered in the report in the sleep disorder treatment market are Jazz Pharmaceuticals, Inc., Pfizer Inc., Viatris Inc., Amneal Pharmaceuticals LLC, Taj Pharmaceuticals Limited, Eli Lilly and Company, Alembic Pharmaceuticals Limited, Apotex Inc., Dr. Reddy’s Laboratories Ltd., Koninklijke Philips N.V., ResMed, SomnoMed, Oventus and BMC Medical Co., among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the sleep disorder treatment market.

  • In November 2019, Pfizer, Inc. announced that its division named Upjohn is combined with Mylan N.V. and formed a new company named Viatris. This combination of the business division of the company with Mylan N.V. has increased its product portfolio leading to increased demand for its product in the market.

 This new product launched by the company has increased its protein estimation portfolio in the market. Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the sleep disorder treatment market which also provides the benefit for organisation to improve their offering for sleep disorder treatment market.


SKU-
Why Choose Us


Frequently Asked Questions